I. Buajordet

Drug-related deaths in a department of internal medicine.

J. Erikssen, L. Sandvik, J. Ebbesen, 2001, Archives of internal medicine.

Fatal adverse drug events: the paradox of drug treatment

J. Ebbesen, I. Buajordet, J. Erikssen, 2001, Journal of internal medicine.

Adverse events after naloxone treatment of episodes of suspected acute opioid overdose

I. Buajordet, O. Brørs, D. Jacobsen, 2004, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.

J. Bergh, C. Gisselbrecht, I. Buajordet, 2019, The oncologist.

Risk of fetal death after pandemic influenza virus infection or vaccination.

A. Wilcox, S. Vollset, P. Nafstad, 2013, The New England journal of medicine.

Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital

I. Buajordet, O. Brørs, F. Wesenberg, 2002, Acta paediatrica.

The role of pharmacoepidemiological studies in the market withdrawal of carisoprodol (Somadril®) in Europe.

I. Buajordet, S. Skurtveit, J. Bramness, 2008 .

[Statins--the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database].

I. Buajordet, H. Olsen, S. Madsen, 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Risk of fetal death after pandemic influenza virus infection or vaccination.

A. Wilcox, S. Vollset, P. Nafstad, 2013, The New England journal of medicine.

[Drugs as a cause of death. A prospective quality assurance project in a department of medicine].

J. Ebbesen, I. Buajordet, J. Erikssen, 1995, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.